Vicarious Surgical (NYSE:RBOT) Given New $7.00 Price Target at Piper Sandler

Key Points

• Piper Sandler has reduced the price target for Vicarious Surgical (NYSE:RBOT) from $8.50 to $7.00, indicating a potential downside of 23.33%.
• The company recently reported an EPS of ($2.23), beating consensus estimates by $0.38, while analysts predict a -10.89 EPS for the current fiscal year.
• Institutional investors own 47.27% of Vicarious Surgical's stock, with notable increases in holdings from firms like Geode Capital Management and Renaissance Technologies.

Vicarious Surgical (NYSE:RBOT - Get Free Report) had its price objective reduced by stock analysts at Piper Sandler from $8.50 to $7.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. Piper Sandler's price objective would indicate a potential downside of 23.33% from the company's current price.

Vicarious Surgical Stock Performance

Shares of RBOT traded down $1.22 during midday trading on Wednesday, hitting $9.13. 47,027 shares of the stock were exchanged, compared to its average volume of 28,870. Vicarious Surgical has a 52-week low of $5.00 and a 52-week high of $19.00. The stock has a fifty day simple moving average of $8.76 and a 200 day simple moving average of $8.88. The firm has a market cap of $54.14 million, a P/E ratio of -0.87 and a beta of 1.41.

Vicarious Surgical (NYSE:RBOT - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($2.23) EPS for the quarter, beating the consensus estimate of ($2.61) by $0.38. As a group, equities research analysts forecast that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its stake in Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company's stock worth $405,000 after purchasing an additional 2,336 shares during the period. Renaissance Technologies LLC lifted its stake in Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company's stock valued at $152,000 after acquiring an additional 1,200 shares during the last quarter. DDD Partners LLC lifted its stake in Vicarious Surgical by 15.3% in the first quarter. DDD Partners LLC now owns 213,824 shares of the company's stock valued at $1,403,000 after acquiring an additional 28,357 shares during the last quarter. Finally, DNB Asset Management AS grew its holdings in Vicarious Surgical by 12.1% during the second quarter. DNB Asset Management AS now owns 29,199 shares of the company's stock valued at $219,000 after purchasing an additional 3,154 shares during the last quarter. 47.27% of the stock is currently owned by institutional investors.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.